Gijtenbeek RGP, et al. Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC). P4658. ERS 2019, 30 sept, Madrid, Spanje.
MUC5B-promotervariant rs35705950 risicofactor voor RA-geassocieerde ILD
feb 2019 | ILD, Pneumonie, Reumatoïde artritis